Overview
Balance Sheet
Cash Flow
Growth Analysis
2024
2023
2022
2021
2020
Profitability Metrics
Gross Margin
90.23%
Operating Margin
115.12%
Net Margin
99.23%
Efficiency Metrics
Revenue per Expense Ratio
129.75
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
115.03%
Income Tax Rate
0.00%
EPS
1.4700000000
Balance Sheet Analysis
Current Ratio
903,341.0
Cash Ratio
903,341.0
Working Capital
$1.36M
Debt to Equity
0.26
Debt to Assets
20.25%
Equity Ratio
78.54%
Cash Flow Analysis
Operating Cash Flow Ratio
102.38%
Free Cash Flow Ratio
102.38%
CapEx to Revenue
0.00%
Dividends Paid
$41.90M
Stock Buybacks
No buybacks
Total Shareholder Returns
$41.90M
Cash Position Change
-15.57%
Key Takeaways (2024 FY)
Maintained positive net income growth despite revenue changes
Detailed Growth Metrics
Core Performance
Revenue
141.28%
Net Income
143.86%
EPS
145.00%
Operating Income
182.91%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
1.88%
Operating Cash Flow
43.87%
Free Cash Flow
43.87%
Balance Sheet Health
Assets
0.21%
Debt
-7.69%
Book Value per Share
1.50%
Inventory
-100.00%
Shareholder Returns
Dividends per Share
0.00%
Shares Outstanding
0.00%
Long Term Trends
3Y Revenue/Share
198.47%
5Y Revenue/Share
1,270.45%
3Y Dividend/Share
0.00%
5Y Dividend/Share
2.97%